Clara V Alvarez

12PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Non-genetically modified uses of biotechnologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 02, 2025
RET signalling in the pituitary: a double-edged sword for differentiation, apoptosis and therapeutic strategies in acromegaly.

Miguel Chenlo, Ignacio Bernabeu, Márta Korbonits

|Jul 11, 2024
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe.

Joana S Rodrigues, Miguel Chenlo, Susana B Bravo

|May 14, 2024
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe.

Joana S Rodrigues, Miguel Chenlo, Susana B Bravo

|Nov 06, 2023
Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.

Angela R Garcia-Rendueles, Miguel Chenlo, Fernando Oroz-Gonjar

|Sep 23, 2022
Tackling Thyroid Cancer in Europe-The Challenges and Opportunities.

Denis Horgan, Dagmar Führer-Sakel, Paula Soares

|Feb 25, 2022
The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis.

Diego Caicedo, Clara V Alvarez, Sihara Perez-Romero

Pageof 2